Some healthcare providers have prescribed BPC-157 through compounding pharmacies, though the FDA has increased scrutiny of compounded peptides in recent years and regulations continue to evolve
We disclose this commercial interest in methodology and in the editorial disclosure below, and address it by writing the version that lets a reader evaluate at-home microinfusion on its merits
Continue peptides through illness unless specifically contraindicated
Frequency depends on the injection, your goals, and your response
Products are not intended for the preparation, reconstitution, dilution, combination, or transfer of any substance for administration to humans or animals, and are not intended to be used in conjunction with any other products for such purposes